
### [MONDO:0002728](http://purl.obolibrary.org/obo/MONDO_0002728)
**Label:** rhabdoid tumor

**Subclasses:** [MONDO:0012252](http://purl.obolibrary.org/obo/MONDO_0012252) (rhabdoid tumor predisposition syndrome 1), [MONDO:0013224](http://purl.obolibrary.org/obo/MONDO_0013224) (rhabdoid tumor predisposition syndrome 2), [MONDO:0000539](http://purl.obolibrary.org/obo/MONDO_0000539) (striated muscle rhabdoid tumor), [MONDO:0002729](http://purl.obolibrary.org/obo/MONDO_0002729) (kidney rhabdoid cancer), [MONDO:0016473](http://purl.obolibrary.org/obo/MONDO_0016473) (familial rhabdoid tumor), [MONDO:0020560](http://purl.obolibrary.org/obo/MONDO_0020560) (atypical teratoid rhabdoid tumor), 

**Mapped go classes:** [GO:0016887](http://purl.obolibrary.org/obo/GO_0016887) (ATPase activity), [GO:0006281](http://purl.obolibrary.org/obo/GO_0006281) (DNA repair), [GO:0008285](http://purl.obolibrary.org/obo/GO_0008285) (negative regulation of cell proliferation), [GO:0000978](http://purl.obolibrary.org/obo/GO_0000978) (RNA polymerase II proximal promoter sequence-specific DNA binding), [GO:0021634](http://purl.obolibrary.org/obo/GO_0021634) (optic nerve formation), [GO:0000980](http://purl.obolibrary.org/obo/GO_0000980) (RNA polymerase II distal enhancer sequence-specific DNA binding), [GO:0005524](http://purl.obolibrary.org/obo/GO_0005524) (ATP binding), [GO:0006338](http://purl.obolibrary.org/obo/GO_0006338) (chromatin remodeling), [GO:0000185](http://purl.obolibrary.org/obo/GO_0000185) (activation of MAPKKK activity), [GO:0003406](http://purl.obolibrary.org/obo/GO_0003406) (retinal pigment epithelium development), [GO:0003407](http://purl.obolibrary.org/obo/GO_0003407) (neural retina development), [GO:0001947](http://purl.obolibrary.org/obo/GO_0001947) (heart looping), [GO:0016514](http://purl.obolibrary.org/obo/GO_0016514) (SWI/SNF complex), [GO:0006351](http://purl.obolibrary.org/obo/GO_0006351) (transcription, DNA-templated), [GO:0030182](http://purl.obolibrary.org/obo/GO_0030182) (neuron differentiation), [GO:0014032](http://purl.obolibrary.org/obo/GO_0014032) (neural crest cell development), [GO:0031492](http://purl.obolibrary.org/obo/GO_0031492) (nucleosomal DNA binding), [GO:0016817](http://purl.obolibrary.org/obo/GO_0016817) (hydrolase activity, acting on acid anhydrides), [GO:0006355](http://purl.obolibrary.org/obo/GO_0006355) (regulation of transcription, DNA-templated), [GO:0000228](http://purl.obolibrary.org/obo/GO_0000228) (nuclear chromosome), [GO:0060059](http://purl.obolibrary.org/obo/GO_0060059) (embryonic retina morphogenesis in camera-type eye), [GO:0006337](http://purl.obolibrary.org/obo/GO_0006337) (nucleosome disassembly), [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation), [GO:0060973](http://purl.obolibrary.org/obo/GO_0060973) (cell migration involved in heart development), [GO:0006357](http://purl.obolibrary.org/obo/GO_0006357) (regulation of transcription by RNA polymerase II), [GO:0003677](http://purl.obolibrary.org/obo/GO_0003677) (DNA binding), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0007417](http://purl.obolibrary.org/obo/GO_0007417) (central nervous system development), [GO:0042393](http://purl.obolibrary.org/obo/GO_0042393) (histone binding), [GO:0043044](http://purl.obolibrary.org/obo/GO_0043044) (ATP-dependent chromatin remodeling), [GO:0048596](http://purl.obolibrary.org/obo/GO_0048596) (embryonic camera-type eye morphogenesis), [GO:0030154](http://purl.obolibrary.org/obo/GO_0030154) (cell differentiation), [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration), [GO:0010842](http://purl.obolibrary.org/obo/GO_0010842) (retina layer formation), [GO:0015616](http://purl.obolibrary.org/obo/GO_0015616) (DNA translocase activity), 

**Class expressions from DL-Learner:**

- [GO:0060038](http://purl.obolibrary.org/obo/GO_0060038) (cardiac muscle cell proliferation) 53.57%
- [GO:0031101](http://purl.obolibrary.org/obo/GO_0031101) (fin regeneration) 53.57%
- Thing 52.39%
- [GO:0033002](http://purl.obolibrary.org/obo/GO_0033002) (muscle cell proliferation) 38.93%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) 38.93%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001221](http://purl.obolibrary.org/obo/GO_2001221) (obsolete positive regulation of G2 phase of mitotic cell cycle)) 38.93%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001220](http://purl.obolibrary.org/obo/GO_2001220) (obsolete negative regulation of G2 phase of mitotic cell cycle)) 38.93%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001219](http://purl.obolibrary.org/obo/GO_2001219) (obsolete positive regulation of S/G2 transition of mitotic cell cycle)) 38.93%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001218](http://purl.obolibrary.org/obo/GO_2001218) (obsolete negative regulation of S/G2 transition of mitotic cell cycle)) 38.93%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001217](http://purl.obolibrary.org/obo/GO_2001217) (obsolete regulation of S/G2 transition of mitotic cell cycle)) 38.93%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001052](http://purl.obolibrary.org/obo/GO_2001052) (null)) 38.93%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001048](http://purl.obolibrary.org/obo/GO_2001048) (null)) 38.93%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001047](http://purl.obolibrary.org/obo/GO_2001047) (null)) 38.93%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2001041](http://purl.obolibrary.org/obo/GO_2001041) (null)) 38.93%
- [GO:0014855](http://purl.obolibrary.org/obo/GO_0014855) (striated muscle cell proliferation) and ([GO:0008150](http://purl.obolibrary.org/obo/GO_0008150) (biological_process) or [GO:2000976](http://purl.obolibrary.org/obo/GO_2000976) (obsolete regulation of transcription from RNA polymerase II promoter involved in detection of glucose)) 38.93%


